Key facts
- This page summarizes Thomas E. Ichim's Form 4 filing for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Jul 2021, 20:54.
Thomas E. Ichim - 20 Jul 2021 Form 4 Insider Report for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
- Reporting relationship
- Director
- Issuer ticker
- CELZ
- Reported as of
- 20 Jul 2021
- Net transaction value
- -$132,405
- SEC form
- 4
- Accepted by SEC
- 22 Jul 2021, 20:54:06 UTC
- Prior SEC filing
- 16 Jul 2021
- Next SEC filing
- 30 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Ichim
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas E. Ichim filed Form 4 for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) on 22 Jul 2021.
Change
- Previous filing in this sequence was filed on 16 Jul 2021.
- Current net transaction value: -$132,405.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CELZ
transaction
Common Stock
Sale
- Transaction value
- $42,560
- Shares
- -1,400,000
- Change %
- -16%
- Price
- $0.0304
- Shares after
- 7,479,522
- Date
- 20 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
CELZ
transaction
Common Stock
Sale
- Transaction value
- $46,200
- Shares
- -1,500,000
- Change %
- -20%
- Price
- $0.0308
- Shares after
- 5,979,522
- Date
- 21 Jul 2021
- Ownership
- Direct
- Footnotes
- F2
CELZ
transaction
Common Stock
Sale
- Transaction value
- $43,645
- Shares
- -1,450,000
- Change %
- -24%
- Price
- $0.0301
- Shares after
- 4,529,522
- Date
- 22 Jul 2021
- Ownership
- Direct
- Footnotes
- F3
CELZ
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,245
- Date
- 20 Jul 2021
- Ownership
- By LLC
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.
Footnote F2
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
Footnote F3
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
Footnote F4
Shares are held by BioTech Holdings, LLC, of which the reporting person is President. The reporting person disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.